Typically, anti-inflammatory action comes from inhaled corticosteroids ... The drug, ensifentrine, is the first new type of maintenance treatment for COPD in over a decade. In clinical trials ...

AstraZeneca’s new inhaler Bevespi Aerosphere (glycopyrronium/formoterol fumarate) has been approved in Europe, as a maintenance treatment for chronic obstructive ...

From innovative new lung valves to refinements in the deployment of inhaled therapies and vaccines, the landscape of COPD care and treatment is changing. Arguably the most buzzed about advancement in ...

After years of limited advancements in chronic obstructive pulmonary disease (COPD) treatment, patients now have new options.

Boehringer Ingelheim has secured first European approvals for its new once-daily treatment ... inhalation from indoor cooking in developing countries. Forty percent of women diagnosed with COPD ...

Flare-ups in chronic obstructive pulmonary disease, the UK’s fourth leading cause of death ... More than a thousand of these were given a new inhaler to manage their condition, which contains three ...

There is an increasing interest in the frequency of COPD exacerbations, since this was found to relate to prevention and treatment. Most of the new drugs being investigated and developed are ...

A new study published in the journal of Respiratory Medicine showed that patients with type 2 inflammation and chronic ...

Researchers are looking at ways to boost the performance and lower the environmental impact of millions of inhalers used for treating asthma and COPD. Working with drug manufacturer Kindeva, ...

This came after Zydus Healthcare presented the proposal for grant of permission for manufacturing and marketing of the drug ...

The expectations of the treatment ... rescue inhalers is a very good tool to measure how the COPD is progressing. Other questions that need to be asked are whether the patient has new associated ...